Status:
COMPLETED
Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)
Lead Sponsor:
Organon and Co
Conditions:
Hypertension
Eligibility:
All Genders
25-74 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate antihypertensive (lowering blood pressure) effectiveness of three combinations of approved study drugs compared to both study drugs being given alone.
Detailed Description
The duration of treatment is 3.5 months.
Eligibility Criteria
Inclusion
- Japanese ancestry
- Stable high blood pressure defined by the study criteria
Exclusion
- Pregnant or nursing
- Significant concurrent kidney, liver, blood, or other disease
- Recent heart attack or heart surgery
- History of stroke, severe hypertension (high blood pressure), significant heart failure or cardiac arrhythmias
- Significant lab abnormalities
- Uncontrolled blood sugar
- History of certain drug allergies
Key Trial Info
Start Date :
April 1 2002
Trial Type :
INTERVENTIONAL
End Date :
November 1 2002
Estimated Enrollment :
840 Patients enrolled
Trial Details
Trial ID
NCT00092209
Start Date
April 1 2002
End Date
November 1 2002
Last Update
February 15 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.